GlassScriptPhysician profile
Haleigh Marlowe
NPI 1760147938
$2,116.43
in general payments reported to CMS, 2019-2025
32 companies · $709 in 2025
The $709 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $632 · 2024: $775 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,116.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $266.91 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $250.83 | 2023-2025 | |
| Incyte Corporation | $211.92 | 2024-2025 | Opzelura |
| Ucb, INC. | $170.22 | 2023-2025 | Bimzelx, Nayzilam |
| Lilly USA, LLC | $168.95 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $147.98 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $98.88 | 2024-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $95.94 | 2024-2025 | Tremfya, Simponi Aria, Simponi |
| Novartis Pharmaceuticals Corporation | $89.12 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $78.56 | 2023-2024 | Verquvo, Belsomra, Steglatro |
| Mylan Specialty L.P. | $62.34 | 2023 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $48.09 | 2024 | Sotyktu, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.38 | 2023-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $33.21 | 2023 | |
| Sanofi US Services INC. | $29.75 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $29.44 | 2024 | Vtama |
| Pfizer INC. | $24.18 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.02 | 2025 | Cabtreo, Siliq, Jublia |
| Mayne Pharma Commercial LLC | $22.98 | 2024 | |
| Verrica Pharmaceuticals INC. | $20.81 | 2024 | Ycanth |
| Botanix Sb INC | $20.37 | 2025 | Sofdra |
| Antares Pharma, INC. | $20.21 | 2023 | Nocdurna, Xyosted, Tlando |
| Leo Pharma INC. | $18.32 | 2024 | Adbry |
| Exact Sciences Corporation | $17.94 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.73 | 2023 | Trulance, Xifaxan |
| Astrazeneca Pharmaceuticals LP | $16.59 | 2023 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $16.54 | 2023 | Nuedexta |
| Esperion Therapeutics, INC. | $15.96 | 2024 | Nexletol |
| Sun Pharmaceutical Industries INC. | $15.16 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $13.44 | 2023 | Inpefa |
| Xeris Pharmaceuticals, INC. | $13.38 | 2023 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $13.28 | 2023 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haleigh Marlowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.